Related references
Note: Only part of the references are listed.S110, a 5-Aza-2′-Deoxycytidine-Containing Dinucleotide, Is an Effective DNA Methylation Inhibitor In vivo and Can Reduce Tumor Growth
Jody C. Chuang et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Cancer/testis (CT) antigens: Potential targets for immunotherapy
Otavia L. Caballero et al.
CANCER SCIENCE (2009)
Epigenetic drugs as pleiotropic agents in cancer treatment:: Biomolecular aspects and clinical applications
Luca Sigalotti et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Delivery of 5-aza-2′-deoxycytidine to cells using oligodeoxynucleotides
Christine B. Yoo et al.
CANCER RESEARCH (2007)
Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2′-deoxycytidine in cutaneous melanoma:: Immunotherapeutic implications
Ester Fonsatti et al.
CLINICAL CANCER RESEARCH (2007)
Levels of specific peptide-HLA class I complex predicts tumor cell susceptibility to CTL killing
Jon A. Weidanz et al.
JOURNAL OF IMMUNOLOGY (2006)
Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura
David S. Schrump et al.
CLINICAL CANCER RESEARCH (2006)
Phenotypic and functional changes of human melanoma xenografts induced by DNA hypomethylation: Immunotherapeutic implications
S Coral et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
ICAM-1 co-stimulates target cells to facilitate antigen presentation
T Lebedeva et al.
CURRENT OPINION IN IMMUNOLOGY (2005)
Methylation-regulated expression of cancer testis antigens in primary effusion lymphoma:: Immunotherapeutic implications
L Calabrò et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2′-deoxycytidine
L Sigalotti et al.
CANCER RESEARCH (2004)
MethPrimer: designing primers for methylation PCRs
LC Li et al.
BIOINFORMATICS (2002)
Sequential 5-aza-2′-deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1
TS Weiser et al.
JOURNAL OF IMMUNOTHERAPY (2001)
Induction of MAGE-3 expression in lung and esophageal cancer cells
TS Weiser et al.
ANNALS OF THORACIC SURGERY (2001)
Share Paper
